Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
16
|
| pubmed:dateCreated |
1998-6-4
|
| pubmed:language |
swe
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0023-7205
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
95
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1772-4
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:9599482-Drug Prescriptions,
pubmed-meshheading:9599482-Drug Utilization,
pubmed-meshheading:9599482-Humans,
pubmed-meshheading:9599482-Informed Consent,
pubmed-meshheading:9599482-Quality Assurance, Health Care,
pubmed-meshheading:9599482-Registries,
pubmed-meshheading:9599482-Safety,
pubmed-meshheading:9599482-Sweden
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
[An answer to Claes Ortendahl: how is the consent to be included in the new drug registry].
|
| pubmed:publicationType |
Journal Article
|